How long can a breastfeeding woman safely take combination estrogen and progesterone (hormonal) birth control pills while breastfeeding?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 10, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Timing of Combined Hormonal Contraception During Breastfeeding

Breastfeeding women should not use combined estrogen-progesterone contraceptive pills until at least 6 weeks postpartum, and generally should avoid them entirely during breastfeeding if possible due to potential effects on milk production. 1

Safety Timeline for Combined Hormonal Contraception During Breastfeeding

The timing of combined hormonal contraceptive (CHC) use during breastfeeding follows these guidelines:

  1. First 3 weeks postpartum (0-21 days):

    • Absolutely contraindicated (U.S. MEC 4) regardless of breastfeeding status
    • Primary concern: Increased risk of venous thromboembolism 1
  2. Week 4 postpartum (21-28 days):

    • Generally not recommended (U.S. MEC 3) for breastfeeding women
    • Concerns: Potential negative effects on breastfeeding establishment and milk production 1
  3. 1 month to <6 months postpartum:

    • Use with caution (U.S. MEC 2)
    • May reduce milk volume and potentially affect infant growth 1, 2
  4. ≥6 months postpartum:

    • Safer to use (U.S. MEC 2) if breastfeeding is well-established
    • Less concern about impact on milk supply at this stage 1

Impact on Breastfeeding and Infant

The primary concerns with combined hormonal contraceptives during breastfeeding include:

  • Milk production: Estrogen component may decrease milk volume, particularly in early postpartum period 2
  • Infant growth: Some older studies showed potential negative effects on infant weight gain when mothers used CHCs 2
  • Milk composition: Potential minor changes in milk composition, though evidence is inconsistent 2

Sex of the Infant

The sex of the breastfeeding infant (boy in this case) does not affect recommendations regarding the use of combined hormonal contraception. The guidelines apply regardless of the infant's sex.

Alternative Contraceptive Options

For breastfeeding women, consider these alternatives in order of preference:

  1. Non-hormonal methods: IUD, barrier methods, fertility awareness
  2. Progestin-only methods: Progestin-only pills, implants, or injections can be used immediately postpartum without affecting milk production 3
  3. Combined hormonal methods: Last resort option after 6 weeks postpartum if other methods are not suitable 1, 4

Common Pitfalls to Avoid

  • Starting too early: Initiating CHCs before 21 days postpartum significantly increases thromboembolism risk 1
  • Ignoring early warning signs: Watch for decreased milk production, infant hunger cues, or slowed infant weight gain
  • Overlooking risk factors: Women with additional risk factors for venous thromboembolism should avoid CHCs for 4-6 weeks postpartum 1
  • Inadequate follow-up: Monitor infant growth and milk production if CHCs are used

Bottom Line

While combined hormonal contraceptives can technically be used after 6 weeks postpartum in breastfeeding women, they should be avoided when possible due to potential negative effects on milk production. The infant's sex does not influence this recommendation. Progestin-only or non-hormonal methods are preferable alternatives during the breastfeeding period.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.